Neuronetics to Report Fourth Quarter and Fiscal Year 2020 Financial and Operating Results and Host Conference Call
February 16 2021 - 7:00AM
Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical
technology company focused on designing, developing and marketing
products that improve the quality of life for patients who suffer
from psychiatric disorders, today announced that it plans to
release fourth quarter and fiscal year 2020 financial and operating
results, and certain guidance for the first quarter and full year
2021, prior to market open on Tuesday, March 2, 2021. The Company
will host a conference call to review its results at 8:30 a.m.
Eastern Time the same day.The conference call will be
broadcast live in listen-only mode via a webcast on the Company’s
investor relations website
at
ir.neuronetics.com. To listen to the
conference call on your telephone, please dial (877) 472-8990
for United States callers or +1 (629) 228-0778 for
international callers and reference confirmation code 2124449,
approximately ten minutes prior to start time. The replay will be
available on the Company's website for approximately 60
days.
About NeuroneticsNeuronetics, Inc. is a
commercial-stage medical technology company focused on designing,
developing, and marketing products that improve the quality of life
for patients who suffer from psychiatric disorders. Our first
commercial product, the NeuroStar® Advanced Therapy System, is a
non-invasive and non-systemic office-based treatment that uses
transcranial magnetic stimulation, or TMS, to create a pulsed,
MRI-strength magnetic field that induces electrical currents
designed to stimulate specific areas of the brain associated with
mood. The system is cleared by the United States Food and Drug
Administration, or FDA, for the treatment of major depressive
disorder in adult patients who have failed to achieve satisfactory
improvement from prior antidepressant medication in the current
episode. Additional information can be found at
www.neuronetics.com.Investor Contact:Mark R.
KlausnerWestwicke
Partners443-213-0501
ir@neuronetics.comMedia
Contact:Chelsey MankoVault
Communications610-455-2778
cmanko@vaultcommunications.com
Neuronetics (NASDAQ:STIM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Neuronetics (NASDAQ:STIM)
Historical Stock Chart
From Apr 2023 to Apr 2024